Cargando…
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing antibodies (NAbs) and IgG antibodies against the S1...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525617/ https://www.ncbi.nlm.nih.gov/pubmed/34668145 http://dx.doi.org/10.1007/s15010-021-01705-7 |
_version_ | 1784585713109434368 |
---|---|
author | Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Marín-Hernández, Antonio Ortiz-León, María Cristina Gómez-Ñañez, Iván Gutiérrez, Michelle Espinosa, Rafaela Sampieri, Clara Luz Ramos, Celso López-Guerrero, Delia Vanesa Zenteno-Cuevas, Roberto Pérez-Carreón, Julio Isael Canales-Vázquez, Guadalupe Montero, Hilda |
author_facet | Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Marín-Hernández, Antonio Ortiz-León, María Cristina Gómez-Ñañez, Iván Gutiérrez, Michelle Espinosa, Rafaela Sampieri, Clara Luz Ramos, Celso López-Guerrero, Delia Vanesa Zenteno-Cuevas, Roberto Pérez-Carreón, Julio Isael Canales-Vázquez, Guadalupe Montero, Hilda |
author_sort | Guzmán-Martínez, Oscar |
collection | PubMed |
description | BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing antibodies (NAbs) and IgG antibodies against the S1 subunit (S1 IgG ) of SARS-CoV-2 and their possible duration were determined through decay models. METHODS: 132 participants with SARS-CoV-2 infection were classified according to the severity of the disease. Seroconversion and persistence of S1 IgG antibodies and NAbs were determined by ELISA, samples were taken at two different times post-infection and duration of those antibodies was estimated using Linear Mixed Models (LMMs). RESULTS: The highest amount of S1 IgGs antibodies was associated with age (41 years or older), greater severity of COVID-19 and male gender. NAbs production was associated with the same variables, except for age. The percentage of NAbs decay is higher in the asymptomatic group (P = 0.033), while in S1 IgG antibodies decay, no statistical difference was found between the 4 severity groups. An exponential decay model was built by using a LMM and similarly, two dispersion regions where constructed. The duration of S1 IgG antibodies was 744 days (668–781) for first region and 744 days (453–1231) for the second. Regarding NAbs, an adaptative LMM was used to model a logistic function, determining a duration of 267 days (215–347). CONCLUSION: Humoral immunity to SARS-CoV-2 infection depends on the severity of the disease, gender and age. This immune response could be long-lasting as for other coronaviruses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01705-7. |
format | Online Article Text |
id | pubmed-8525617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85256172021-10-20 Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Marín-Hernández, Antonio Ortiz-León, María Cristina Gómez-Ñañez, Iván Gutiérrez, Michelle Espinosa, Rafaela Sampieri, Clara Luz Ramos, Celso López-Guerrero, Delia Vanesa Zenteno-Cuevas, Roberto Pérez-Carreón, Julio Isael Canales-Vázquez, Guadalupe Montero, Hilda Infection Original Paper BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing antibodies (NAbs) and IgG antibodies against the S1 subunit (S1 IgG ) of SARS-CoV-2 and their possible duration were determined through decay models. METHODS: 132 participants with SARS-CoV-2 infection were classified according to the severity of the disease. Seroconversion and persistence of S1 IgG antibodies and NAbs were determined by ELISA, samples were taken at two different times post-infection and duration of those antibodies was estimated using Linear Mixed Models (LMMs). RESULTS: The highest amount of S1 IgGs antibodies was associated with age (41 years or older), greater severity of COVID-19 and male gender. NAbs production was associated with the same variables, except for age. The percentage of NAbs decay is higher in the asymptomatic group (P = 0.033), while in S1 IgG antibodies decay, no statistical difference was found between the 4 severity groups. An exponential decay model was built by using a LMM and similarly, two dispersion regions where constructed. The duration of S1 IgG antibodies was 744 days (668–781) for first region and 744 days (453–1231) for the second. Regarding NAbs, an adaptative LMM was used to model a logistic function, determining a duration of 267 days (215–347). CONCLUSION: Humoral immunity to SARS-CoV-2 infection depends on the severity of the disease, gender and age. This immune response could be long-lasting as for other coronaviruses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01705-7. Springer Berlin Heidelberg 2021-10-19 2022 /pmc/articles/PMC8525617/ /pubmed/34668145 http://dx.doi.org/10.1007/s15010-021-01705-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Marín-Hernández, Antonio Ortiz-León, María Cristina Gómez-Ñañez, Iván Gutiérrez, Michelle Espinosa, Rafaela Sampieri, Clara Luz Ramos, Celso López-Guerrero, Delia Vanesa Zenteno-Cuevas, Roberto Pérez-Carreón, Julio Isael Canales-Vázquez, Guadalupe Montero, Hilda Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title | Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title_full | Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title_fullStr | Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title_full_unstemmed | Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title_short | Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients |
title_sort | generation and persistence of s1 igg and neutralizing antibodies in post-covid-19 patients |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525617/ https://www.ncbi.nlm.nih.gov/pubmed/34668145 http://dx.doi.org/10.1007/s15010-021-01705-7 |
work_keys_str_mv | AT guzmanmartinezoscar generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT guardadokathia generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT varelacardosomiguel generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT trujilloriveraalejandro generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT marinhernandezantonio generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT ortizleonmariacristina generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT gomeznanezivan generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT gutierrezmichelle generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT espinosarafaela generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT sampiericlaraluz generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT ramoscelso generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT lopezguerrerodeliavanesa generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT zentenocuevasroberto generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT perezcarreonjulioisael generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT canalesvazquezguadalupe generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients AT monterohilda generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients |